Page last updated: 2024-10-25

ciglitazone and Local Neoplasm Recurrence

ciglitazone has been researched along with Local Neoplasm Recurrence in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research Excerpts

ExcerptRelevanceReference
"Most thyroid cancers are slow-growing, easily treatable tumors with an excellent prognosis after surgical resection and targeted medical therapy."2.43Identification and treatment of aggressive thyroid cancers. Part 2: risk assessment and treatment. ( Angelos, P; Sturgeon, C, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sturgeon, C1
Angelos, P1

Reviews

1 review available for ciglitazone and Local Neoplasm Recurrence

ArticleYear
Identification and treatment of aggressive thyroid cancers. Part 2: risk assessment and treatment.
    Oncology (Williston Park, N.Y.), 2006, Volume: 20, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Cisplat

2006